Personalis Total Current Liabilities 2018-2025 | PSNL
Personalis total current liabilities from 2018 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Personalis Annual Total Current Liabilities
(Millions of US $) |
| 2024 |
$31 |
| 2023 |
$47 |
| 2022 |
$33 |
| 2021 |
$31 |
| 2020 |
$41 |
| 2019 |
$50 |
| 2018 |
$58 |
| 2017 |
$0 |
Personalis Quarterly Total Current Liabilities
(Millions of US $) |
| 2025-03-31 |
$30 |
| 2024-12-31 |
$31 |
| 2024-09-30 |
$36 |
| 2024-06-30 |
$34 |
| 2024-03-31 |
$31 |
| 2023-12-31 |
$47 |
| 2023-09-30 |
$32 |
| 2023-06-30 |
$29 |
| 2023-03-31 |
$34 |
| 2022-12-31 |
$33 |
| 2022-09-30 |
$34 |
| 2022-06-30 |
$42 |
| 2022-03-31 |
$40 |
| 2021-12-31 |
$31 |
| 2021-09-30 |
$27 |
| 2021-06-30 |
$34 |
| 2021-03-31 |
$39 |
| 2020-12-31 |
$41 |
| 2020-09-30 |
$36 |
| 2020-06-30 |
$43 |
| 2020-03-31 |
$52 |
| 2019-12-31 |
$50 |
| 2019-09-30 |
$47 |
| 2019-06-30 |
$56 |
| 2019-03-31 |
|
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2017-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.456B |
$0.085B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
